Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-02-02 Sale | 2024-02-05 7:54 pm | Arbutus Biopharma Corp | ABUS | HASTINGS DAVID C Chief Financial Officer | 9,593 | $2.3125 | $22,184 | 631,907 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-01 Option Award | 2024-02-05 7:54 pm | N/A 2034-02-01 | Arbutus Biopharma Corp | ABUS | HASTINGS DAVID C Chief Financial Officer | 562,500 | $0 | 631,907 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-23 4:08 pm | N/A N/A | SCYNEXIS INC | SCYX | HASTINGS DAVID C Director | 10,000 | $0 | 23,183 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-20 8:06 pm | N/A 2033-06-14 | SCYNEXIS INC | SCYX | HASTINGS DAVID C Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-03 4:11 pm | N/A 2033-02-01 | Arbutus Biopharma Corp | ABUS | HASTINGS DAVID C Chief Financial Officer | 395,000 | $0 | 395,000 (Direct) | View |
Ownership | 2023-01-03 9:04 pm | N/A 2038-01-02 | Vascular Biogenics Ltd. | VBLT | HASTINGS DAVID C Director | 0 | $0 | 224,113 (Direct) | View |
| 2022-07-11 Other | 2022-07-11 4:05 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | HASTINGS DAVID C Director | 37,583 | $0 | 0 (Direct) | View |
| 2022-07-11 Disposition | 2022-07-11 4:05 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | HASTINGS DAVID C Director | 27,500 | $2.2 | 0 (Direct) | View |
| 2022-07-07 Equity Swap | 2022-07-11 4:05 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | HASTINGS DAVID C Director | 22,000 | $2.2 | 0 (Direct) | View |
| 2022-06-17 Option Award | 2022-06-22 4:06 pm | N/A 2032-06-16 | SCYNEXIS INC | SCYX | HASTINGS DAVID C Director | 10,000 | $0 | 23,183 (Direct) | View |
| 2021-07-16 Disposition | 2022-02-15 4:01 pm | N/A 2028-04-30 | Entasis Therapeutics Holdings Inc. | ETTX | HASTINGS DAVID C Director | 34,560 | $0 | 26,583 (Direct) | View |
| 2021-07-16 Option Award | 2022-02-15 4:01 pm | N/A 2031-07-15 | Entasis Therapeutics Holdings Inc. | ETTX | HASTINGS DAVID C Director | 26,583 | $0 | 26,583 (Direct) | View |
| 2022-01-20 Option Award | 2022-01-20 5:55 pm | N/A 2032-01-20 | Arbutus Biopharma Corp | ABUS | HASTINGS DAVID C Chief Financial Officer | 285,000 | $2.81 | 285,000 (Direct) | View |
| 2022-01-18 Option Award | 2022-01-19 4:01 pm | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | HASTINGS DAVID C Director | 27,500 | $0 | 49,500 (Direct) | View |
| 2021-06-16 Option Award | 2021-06-21 08:31 am | N/A 2031-06-15 | SCYNEXIS INC | SCYX | HASTINGS DAVID C Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2021-04-01 Option Award | 2021-04-02 10:33 am | N/A N/A | Entasis Therapeutics Holdings Inc. | ETTX | HASTINGS DAVID C Director | 22,000 | $0 | 22,000 (Direct) | View |
| 2020-07-06 Option Award(A) | 2021-03-31 4:04 pm | N/A 2030-07-05 | SCYNEXIS INC | SCYX | HASTINGS DAVID C Director | 55,000 | $0 | 55,000 (Direct) | View |
| 2021-02-13 Option Award | 2021-02-17 5:06 pm | N/A 2031-02-13 | Arbutus Biopharma Corp | ABUS | HASTINGS DAVID C Chief Financial Officer | 250,000 | $0 | 250,000 (Direct) | View |
| 2020-06-10 Option Award | 2020-10-06 4:32 pm | N/A 2030-06-09 | Entasis Therapeutics Holdings Inc. | ETTX | HASTINGS DAVID C Director | 11,000 | $0 | 11,000 (Direct) | View |
| 2020-07-06 Option Award | 2020-07-08 4:11 pm | N/A 2030-07-05 | SCYNEXIS INC | SCYX | HASTINGS DAVID C Director | 45,000 | $0 | 45,000 (Direct) | View |
| 2020-02-17 Option Award | 2020-02-19 08:03 am | N/A 2030-02-17 | Arbutus Biopharma Corp | ABUS | HASTINGS DAVID C Chief Financial Officer | 100,000 | $0 | 100,000 (Direct) | View |
| 2019-06-19 Option Award | 2019-06-21 4:04 pm | N/A 2029-06-18 | Entasis Therapeutics Holdings Inc. | ETTX | HASTINGS DAVID C Director | 7,500 | $0 | 7,500 (Direct) | View |
| 2019-06-18 Option Award | 2019-06-20 1:34 pm | N/A 2029-06-17 | SCYNEXIS INC | SCYX | HASTINGS DAVID C Director | 45,000 | $0 | 45,000 (Direct) | View |